Listed by the USPTO as MARSH, OWEN LEWIS
Tech Center 3700 • Art Units: 3771 3794 3796
This examiner grants 67% of resolved cases
MARSH, OWEN LEWIS is assigned to tech center 3700 and art unit 3771. The profile has 3 resolved cases, a 66.7% allowance rate, and a 50.0% interview lift. The median time to allowance is 780 days. Because the resolved-case base is limited, the figures should be treated as an early directional record.
Listed companies include Boston Scientific Corporation, Medtronic Inc., and Oura Health Oy. Listed firms include Lewis & Reese, PLLC, SEAGER, TUFTE & WICKHEM, LLP, and ADE & COMPANY INC. The available data points to interviews as a potentially useful prosecution tool.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18844091 | DRIVE DEVICE, SURGICAL TOOL DEVICE, ARM DEVICE, AND MASTER-SLAVE SYSTEM | Non-Final OA | SONY GROUP CORPORATION |
| 19023769 | MEDICAL DEVICE AND METHODS OF USE | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18884529 | CIRCULATORY SUPPORT DEVICES, SYSTEMS, AND METHODS | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18992596 | DIRECTABLE LASER CATHETER SONIC WAVE WITH FOCUSING CHAMBER | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 18294496 | ELECTRODES FOR NEUROMODULATION | Final Rejection | Cala Health, Inc. |
| 18976395 | SENSOR GEOMETRY FOR A WEARABLE DEVICE | Non-Final OA | Oura Health Oy |
| 18661985 | TECHNIQUES FOR UTILIZING A MULTI-OUTPUT NEURAL NETWORK | Non-Final OA | Oura Health Oy |
| 19013563 | SYSTEMS AND METHODS OF DETERMINING LOCATION USING A MEDICAL DEVICE | Non-Final OA | ZOLL Medical Corporation |
| 18849671 | REMOTE ARRHYTHMIA DETECTION AND TREATMENT ANALYSIS IN WEARABLE CARDIAC DEVICES | Non-Final OA | ZOLL Medical Corporation |
| 19120156 | CONDUCTION SYSTEM PACING CONTROL | Non-Final OA | Medtronic, Inc. |
| 19104493 | SURROGATE LEFT VENTRICULAR ACTIVATION TIME | Non-Final OA | Medtronic, Inc. |
| 19101446 | HEALTH EVENT PREDICTION USING HEARTBEAT INTERVALS FROM ELECTROCARDIOGRAM DATA | Non-Final OA | Medtronic, Inc. |
| 18871713 | IMPLANTABLE MEDICAL LEAD IMPLANT TOOL | Non-Final OA | Medtronic, Inc. |
| 18987416 | LASER PHACOLYSIS SYSTEM AND METHOD | Non-Final OA | UNIVERSITY OF SOUTH FLORIDA |
| 19044030 | Deep Brain Stimulation Neuromodulation Targeting | Non-Final OA | Boston Scientific Neuromodulation Corporation |
| 18915053 | Use of Brain Anatomical Features to Optimize Deep Brain Stimulation | Final Rejection | Boston Scientific Neuromodulation Corporation |
| 18909601 | SYSTEMS AND METHODS FOR MODULATING THE NEUROIMMUNE SYSTEM | Non-Final OA | Boston Scientific Neuromodulation Corporation |
| 18635292 | DELIVERY TUBE WITH BRAID | Non-Final OA | MAGENTA MEDICAL LTD |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy66.7% of resolved applications examined by Owen Lewis Marsh were allowed (3 resolved cases), compared with 65.9% across Art Unit 3771 over the last five years.
This examiner's interview lift is +50.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Owen Lewis Marsh took 780 days on average from filing to allowance.
Owen Lewis Marsh examines applications in Art Unit 3771 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
